Exploring difficulties in men’s experience of self and agency during antidepressant use by Wood, Max et al.
Wood, Max and Griffiths, John and Paltoglou, Aspasia Eleni (2020) Exploring
difficulties in men’s experience of self and agency during antidepressant use.








Exploring difficulties in men’s experience of self and agency during 
antidepressant use 
Maximillian Wood1 a, Dr. John Griffiths b, Dr. Aspasia E. Paltoglou b 
a University College London, and Camden and Islington NHS Foundation Trust  




Recovery from depression involves active processes of taking back control and reclaiming the 
self. Antidepressant medication can play a critical role in recovery, yet these medications and 
their effects can also become associated with feelings of dependency and loss of self, whilst 
conflicting with social norms, including gender roles. Men may be vulnerable in particular ways 
to these conflicts because of a dominant masculinity that demands independence and self-
control. High levels of non-adherence to prescribed antidepressant regimens in patient 
populations points to the importance of better navigating these socio-cultural and cognitive 
barriers in order to improve treatment outcomes. This study draws from one-on-one 
interviews with six men who speak about their experience of depression and antidepressants, 
and conducts a secondary thematic analysis of the data to explore the difficulties experienced 
around medication use, in particular in relation to these men’s redefinition of self, and exercise 
of agency. The analysis exposed three themes: feelings of altered embodiment and reality, 
concerns about dependency, and the ambivalent nature of masculine roles. It suggests that 
increased agency for men with regards to their therapeutic regimen, and consideration of 
masculine ideals of control and responsibility, could improve the experience of antidepressant 
use. However, the discussion also recommends the integration of medication use within 
treatment models that challenge less healthy aspects of male roles and identities, and allow 
for a diversity of masculinities. 
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Public significance statement: Adherence to antidepressant regimens is frequently poor, and patients 
express reservations around their use. These include difficulties related to sense of self, and identities 
such as gender roles. Men’s conflicts around antidepressant use can be understood in the light of 
masculine norms, and treatment models designed to work with and around these norms could improve 




Evidence-based guidelines recommend antidepressant medication as a first-line treatment for 
moderate to severe depression in adults (Cleare et al., 2015). Clinical trials support its efficacy, 
demonstrating it to be at least superior to placebo, though not always clinically significant in 
its effects (Cleare et al., 2015). Qualitative studies of user experience suggest that 
antidepressants can provide relief, allowing patients to get their “foot in the door” as they 
engage in a variety of purposeful activities on their journey to recovery (Knudsen et al., 2002; 
Lafrance, 2007). It has also been suggested that the biomedical model of depression may have 
a destigmatising effect for some people, by framing depression as a “biochemical” issue, on 
par with other physical illness (Schreiber and Hartrick, 2002).  
However, despite these recommendations and positive findings, studies also report 
high rates of non-adherence to prescribed antidepressant regimens among patients, leading 
to suboptimal treatment, risk of relapse and poor quality of life (van Servellen et al., 2011). 
Studies report discontinuation rates over a six month period following prescription, ranging 
from 30%-60% depending on the population and type of antidepressant (Sirey et al., 2001; 
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Demyttenaere et al., 2001; Sawada et al., 2009), such that from one in three up to over half of 
patients prescribed antidepressants may not adhere to the regimen, often without consulting 
their physician (Demyttenaere et al., 2001; Sawada et al., 2009).  
Many users report concerns in relation to side-effects of the medication (van Servellen 
et al., 2011), including sexual dysfunction, nausea, headache, insomnia, cardiac arrhythmia, 
apathy and weight gain, as well as unpleasant symptoms related to discontinuation (Moret et 
al., 2009). Other variables thought to impact non-adherence include reports of “feeling better” 
before the end of the prescription period (Demyttenaere et al., 2001), preference for different 
treatment models, lack of social support, stigma, and patient scepticism about efficacy (van 
Servellen et al., 2011; Kamaradova et al., 2016).  
Qualitative studies also suggest that users have concerns about a loss of agency and 
identity with regards to the medication (Cartwright et al., 2018). According to Bandura’s social 
cognitive theory (Bandura 1982, 2006), to have agency is to be able to intentionally influence 
one’s own life course, and ‘self-efficacy’ is a person’s belief in their ability to execute courses 
of action required to deal with prospective situations. Research suggests that, for some users, 
antidepressant medication comes to be seen as a sign of “weakness”, with difficulties arising 
especially in long-term use where users come to see themselves as dependent on the 
medication, thus undercutting their agency and self-efficacy beliefs (Cartwright et al., 2018; 
Fullagar, 2009). These conflicts are exacerbated by a wider cultural discourse in which 
emotional problems are seen as a sign of failure, and “man-made” mood-modifying medicines 
are considered to be “unnatural” (Stevenson and Knudsen, 2008). Antidepressant medication 
thus becomes a stigmatized medicine for an already stigmatized condition, and can be 
experienced as a threat to users’ agency and identity at a time when this is most critical. 
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One study found that social support may improve adherence to medication regimen, 
although only in those patients who have a high internal locus of control (Voils et al., 2005). 
There is also evidence that a strong sense of agency is related to lower risk of depression 
(Bandura, 2006) and to lower suicidal ideation, particularly in men (Bryan et al., 2014; Hobbs 
and McLaren, 2009). Furthermore, numerous qualitative studies investigating the lived 
experience of depression and recovery highlight recovery from depression as a process of 
“redefining the self” (Karp, 1994; Schreiber, 1996), implicating issues of belonging (Bygstad-
Landro and Giske, 2017), and a “taking of responsibility” (Ridge and Ziebland, 2006) or “taking 
control” of one’s depression (Fullagar and O’Brien, 2012).  
Research on users’ experience of antidepressant use has also highlighted the 
importance of sex and gender as important variables in expressions of conflict or concern 
about medication use (Gibson et al., 2018; Cartwright, 2018). These include dominant forms 
of masculinity or femininity - the norms, roles and practices held to be normative for males 
and females within a given culture, which are enforced, rewarded and re-created within the 
family unit and within wider social systems and institutions (Kimmel et al. 2005; 
Messerschmidt, 2018; Gibson et al., 2018). Despite the perception that men are usually averse 
to talking therapies and want a ‘quick fix’, studies suggest that men who do engage with mental 
health services prefer psychotherapy to medication as a treatment option (Hernandez et al., 
2014), and that men are less likely than women to want to use prescription medication as a 
way of coping with stress (Liddon et al., 2017). These preferences can be expected to interact 
with and reflect masculinity practices and attitudes. It is noteworthy however that most 
existing research has investigated experiences of antidepressant use within female samples, 
whilst studies using male samples are considerably fewer, perhaps because depression is a 
condition stereotypically associated with women (Emslie et al., 2006; Schreiber, 1996). This is 
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in line with research that suggests that men exhibit more externalized symptoms of distress, 
such as aggression, irritability, risk-taking and substance abuse, while women tend to exhibit 
more internalized symptoms, such as rumination and low mood, consistent with anxiety and 
depression disorders (Smith et al., 2018). But there is also evidence that clinicians and the 
medical establishment may underdiagnose depression in men because of clinician and 
measurement bias, and a lack of research in to the diversity of male experiences of depression 
(Smith et al., 2018). 
An understanding of the male depression phenotype and men’s attitudes to treatment 
is particularly important given that dominant forms of masculinity (as defined by researchers 
in North America, Western Europe and Australasia), are known to involve expressions of 
strength, independence, stoicism, responsibility, achievement and control (Emslie et al., 2006; 
Messerschmidt, 2018; Vogel et al., 2011). These dominant masculinities may make men 
susceptible in unique ways to the conflicts and stigma associated with depression and 
medication, and specifically so with regards to the themes of agency and self that are known 
to be critical in recovery from depression. Existing research on men’s experiences of help-
seeking and depression in the UK show how men seek to reconstruct a valued sense of 
themselves and their own masculinity during recovery (Emslie et al., 2006). More specifically, 
men report struggling to reclaim the strength and independence that is threatened by the lived 
experience of depression, but is demanded of them by dominant gender norms and practices 
(O’Brien et al., 2005; Emslie et al., 2006). Research also suggests that depression can be 
perceived as a risk to one’s ‘status’ relative to other men and women (Courtenay, 2000) and 
that men show strength through restricted emotionality and denial of vulnerability (Gough 
2013; Steward and Harmon, 2004).  
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A study by Gibson et al. (2018), using a sample of men from New Zealand, undertook 
an investigation on men’s conflicts specifically about antidepressant use, and demonstrated 
how participants navigated conflicts between the use of medication and masculine norms and 
practices, in particular in relation to issues of control, sexual performance, emotion, and 
autonomy. To the best of our knowledge, however, no other studies have yet taken as their 
primary objective an investigation of how men’s experiences of antidepressant use interact 
with dominant masculinities, and no studies have investigated this in particular with relation 
to the construction of agency in recovery. Improving efficacy of existing treatments models for 
depression in male populations may hinge on a better understanding of precisely these 
variables. 
This paper seeks to motivate discussion on this topic by presenting an analysis of 
interviews with a sample of six men who agreed to speak about their experience of depression 
and antidepressant use. The analysis was conducted with a view to exploring the following 
questions: What difficulties can negative perceptions and experiences of antidepressant 
medication pose to men’s redefinition of self, and exercise of agency, in their recovery from 
depression? And in what ways do antidepressants sometimes conflict with the participants’ 






Participants were selected by reviewing people’s profiles on the ‘depression’ and ‘experiences 
of antidepressants’ pages in the mental health section of the healthtalk.org website, run by 
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the DIPEx charity in partnership with the Health Experiences Research Group (HERG) at the 
Nuffield Department of Primary Care Health Sciences, University of Oxford. The website 
publishes people’s individual accounts of living with various physical and mental health 
conditions, collected by academic researchers who interview participants in their own homes. 
The archive includes over four thousand narrative interviews approved for secondary analysis. 
The stories are collected for research purposes and are publicly shared online with the aim of 
helping others to feel better prepared and informed, and less alone in their lived experience. 
Inclusion criteria for the study presented in this paper were that the participants be adult 
males, having received a diagnosis of a depressive disorder, and with evidence on the website 
profile of having taken antidepressant medication. There were no exclusion criteria. All 74 
profiles on the ‘depression’ and ‘experiences of antidepressants’ pages were screened, and 22 
met criteria. Six were selected to give a range of ages, and a balance of positive and negative 
experiences with medication use, as evidenced from the interview excerpts on the website. A 
maximum of six transcripts were available for analysis because of restrictions in the data 
sharing agreement signed by Manchester Metropolitan University and Oxford University for 
the purposes of this study.  
The final sample included six men, aged between 29 and 75 at the time of interview, 
drawn from various locations throughout the United Kingdom. Participants varied in how 
recently they had been diagnosed, what kinds of antidepressant they had taken (including 
Sertraline, Venlafaxine/Effexor, Paroxetine and Fluoxetine/Prozac), and whether they were still 
taking antidepressants at the time of the interview. Two participants also reported taking 
lithium. Four participants were married or in a relationship (two of whom had children), and 
two were single. One participant was identified as belonging to a minority ethnic group. The 
interviews were conducted by a female or male sociologist from the HERG, whilst the 
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secondary analysis presented in this study was conducted independently at a later date by a 
male researcher, who has never received a diagnosis of depression. The names referenced 




The interviews were conducted over the course of separate studies by the HERG between 2003 
and 2012. Participants were recruited through social media, patient support groups, 
newsletters, word of mouth, GPs and other clinicians, and took place one-on-one in the 
participants’ homes. For the four interviews drawn from the ‘experience of antidepressants’ 
section of the HERG archive, the interviewer first asked participants to recount their story, in 
particular when their depression first started, how they sought help, what medications they 
were given, and what effect these have had. The interviewer then asked follow-up questions, 
including targeted questions about side-effects of the medication. For the two interviews taken 
from the ‘depression’ section, the interviews were more open-ended. Respondents were given 
as much time as required to talk about their lives in their own words, and to focus on issues 
about depression that were important to them. A topic list was then used in the second part 
of the interview, including life before depression, the period of time when things seemed ‘not 
quite right’, the depression experience, social consequences of depression, help seeking and 
personal coping strategies. All interviews were audio recorded, some were also video 
recorded. The interviews were not time-limited, lasting up to a couple of hours in some cases. 
The interviews were professionally transcribed and returned to participants for review. 
Qualitative thematic analyses of the transcripts, illustrated with excerpts from the interviews, 
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have been published by the HERG on the healthtalk.org website, as well as in publications in 




A critical realist orientation was adopted in asking the research questions that are 
concerned primarily with the content and process of the participants’ experience, whilst 
looking to the material and social realities that shape the production of this experience 
(Ussher, 2010). Critical realism is a methodological framework that aims to understand the 
causal mechanisms underlying social phenomena. Critical realism relies on theories and 
researcher-driven analysis to explore theory-guided questions, in contrast with more data-
driven frameworks such as Grounded Theory (Fletcher, 2017). As Fletcher (2017) illustrates, 
the critical realism researcher’s investigation alternates between the three levels of reality; 
namely the individual’s experience of an event or phenomenon, the event itself, and the causal 
mechanisms underlying the event. 
A thematic analysis was conducted on the transcripts, according with the 
methodological and epistemological approach of much existing research on the topic that has 
asked similar research questions of similar data (e.g. Gibson et al., 2018; Cartwright et al., 
2018). Following a pre-coding familiarization stage (Braun and Clarke, 2006), the transcripts 
were coded using manual scrutiny-based coding techniques (Ryan and Bernard, 2003). Pre-
existing codes were not imposed on the data, though the coding was informed by the existing 
literature, and the specificities of the research question, such that all themes related to agency, 
self, masculinity, recovery and antidepressants were extracted, whilst some themes were also 
extracted more inductively, prompted by the transcripts themselves. Following initial coding, 
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codes were grouped in to sub-themes and finally themes, with an attempt to capture only 
those themes directly relevant to the research question, without losing the complexity and 
novelty presented by the data itself. Three themes were included in the final analysis. The lead 
researcher was responsible for coding the six transcripts. Unfortunately, double coding with 
another researcher was not undertaken in the initial analysis, and the codes had to be disposed 
of before a second data sharing agreement could be signed to allow other researchers to code 
the data. Another two researchers did code one of the transcripts at a later date and found 
evidence for the final themes identified by the lead researcher. Ethical approval for the analysis 
was granted by the Psychology Department Research Ethics Committee at Manchester 




Unreality and disembodiment 
 
Perceived distortions in sense of self and exercise of agency, associated with a sense of altered 
reality and dissociated embodiment, attributed by users as a side effect of the antidepressant 
medication, are well reported in existing research (Read et al., 2014; Gibson et al., 2018), and 
our participants also voiced these concerns. For Tom, one of the most pronounced negative 
effects attributed to the medication was a sense of unreality and disembodiment: 
 
“One of things that I do remember was feeling a sense of distance from the world a 
bit, I felt [um] kind of like what was happening wasn’t really happening” […] “almost 
like I’m, I’m watching what’s going on, I’m not quite fully in my body I’m not fully 
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there [um] and, you know, both pleasure and pain aren’t really experienced to the 
full extent” (Tom) 
 
This concern is consistent with the findings from the Gibson et al. (2018) study, in which the 
men reported being particularly concerned with loss of vitality and sensory engagement, 
rather than loss of empathy or concern for others, which research has suggested may be more 
often reported as a concern for women (Fullagar and O’Brien, 2012). Harry reports a numb 
“dream like state” when he first started taking the medications, whilst George reports “feeling 
constantly flat”, which impacts on his ability to write music, an identity defining occupation 
linked with enjoyment: 
 
“Oh yeah well the first time I started.... completely woozy, completely numified, in a 
dream like state.” (Harry) 
 
“The only problem that I did find with, with lithium, and again with, with, with 
Effexor is it took, it took me away from me, if you wish.  [um] I was no longer myself.  
[um] I was no longer able to do some of the things which I liked doing.  I liked writing 
music and I was, I was unable to do that” (George) 
 
“You know, the idea of, [um] recovering from depression is to make yourself feel well 
again and start enjoying life, but if you’re taking pills which stop you enjoying life, 




Another loss of sensuality and enjoyment reported by some participants related to sexual 
irregularities, with repercussions for the men’s roles as partners within intimate relationships. 
Tom for example noticed a loss of libido, which he connected with the sense of unreality and 
disembodiment, an issue also reported by Peter, which impacted on his relationship with his 
wife: 
 
“I think probably loss of libido to an extent was a [um] which kind of links to what I 
was saying before about just that kind of sense of distance from the world” (Tom) 
 
“I can always remember my wife and, the psychiatrist had to see my wife and she 
complained, she said it was the [um] it was the pills that were making me not 
interested in sex” (Peter) 
 
Giddens (1991) suggests that routine control of the body is integral to the experience of 
agency, as well as carrying on normal functions consistent with an individual’s biographical 
narrative - yet as observed this can come to be disrupted by the loss of sensuality and altered 
embodiment that participants observed consequent to taking the medication. Other 
abnormalities reported by participants included difficulty with ejaculation: 
 
“with Seroxat the first thing I noticed was, [laughs] this is a bit embarrassing, but I 
couldn't ejaculate…” (Samuel) 
 




Women also struggle with the sexual side effects of antidepressant medication (Mullen et al., 
2014), though dominant forms of masculinity are tightly bound to norms of sexual 
“performance” and penetrative intercourse in particular, with loss of libido or erectile 
problems signifying a failure of masculinity (Fergus et al., 2002). In this vein, and as noted in 
the study by Emslie et al. (2006), which draws from some of the same interviews, compared to 
the loss of libido, participants tried to re-frame difficulties with delayed ejaculation in a 
masculinity affirming light by making the analogy with being a “porn star”: 
 
“you know, I’d be a hell of a porn star because I’d keep going for hours [laugh]” 
(George) 
 
“you feel like a sort of porn star, you can go for hours you know [laughs]” (Samuel) 
 
Yet despite trying to reframe the situation, participants were unable to fully normalize this new 
form of embodiment, and it removed enjoyment of sexual activity, which previous research 
has suggested may become a source of distress in itself and further increase feelings of 
depression (Gibson et al., 2018). 
 
“you just think whoa, there's something fucked up in my body [laughs], this isn't the 
way it was supposed to be.” (Samuel) 
 
“Yeah and I, it was kind of annoying, [um] you know, because after half an hour of 





Uncertainty and dependency 
 
Alongside the difficulties associated with an altered sense of reality and embodiment, 
attributed as side effects of the medication, the men also reported conflicts at more “symbolic” 
and “narrative” levels (Knudsen et al., 2002) related in part to their own insight in to the roots 
of their depression. Indeed, whilst participants adopted both biochemical and psychosocial 
perspectives in their accounts, some were clear in preferring the latter model: 
 
“I: So would you say that talking about it was more powerful than taking medicines? 
R: Yeah, yeah, yeah, yeah. I felt when I did the therapy, the group therapy and one to 
one, I thought that most, most valuable” (Peter) 
 
“the brain is something that develops in life it isn’t like a machine that’s fixed at birth 
and it is also continually changing and certainly in our early years [um] and it, you 
know, it changes in response to the relationships and experiences that we have.” 
(Tom) 
 
Medication use was perceived as undermining the self-understandings and “recovery 
narratives” (Danielsson et al., 2009) that some participants had gained through therapy or 
other non-pharmaceutical efforts at recovery, confounding their agency and self-efficacy: 
 
“I had no way of gauging what was making me feel better, you know, was it the pills, 
was it the psychotherapy that I was doing [um] was it my circumstances, what was it 
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I didn’t know and pills were at that moment part of that mix […] I had a sense that it 
was the discussions I was having through the therapy but I didn't really know” (Tom) 
 
“my experience with [um] with the drugs is that I don’t know that they’re not 
working […] I don’t know that, I can’t say they are working as I don’t know whether 
it’s my - additional efforts of just going to see the counsellor once a week” (Harry) 
 
This state of uncertainty and self-doubt accords with the findings from the studies by Fullagar 
(2009), and Lafrance (2007), in which the participants’ non-pharmaceutical therapeutic 
practices were made invisible by the authority invested in biomedical narratives. Faced with 
an uncertainty as to the real foundations of one’s recovery, participants also reported a fear 
of discontinuing the medication, despite a belief that the medications do not really “make any 
difference”. 
“I felt, I just kept on the tablets, I felt they didn’t, I just took them, I felt they didn't 
make any difference to me really but I’ve always been frightened of coming off them 
and in all my time having antidepressants” (Peter) 
 
“Yeah you're terrified of what is going to happen now.  If you said to me okay, stop 
taking Prozac tomorrow, I wouldn’t be able to.” (Samuel) 
 
A state of passive dependence and submission to medical advice is adopted, which we might 
consider to be a form of what Frankenberg (1992) calls the “tragic inevitability” that can come 
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to permeate the identity of the “sick” patient, hindering the building of an agentic self that is 
otherwise crucial to recovery: 
 
“I just kept taking the pills and doing what people told me.” (Peter) 
 
Tom describes the feeling of disempowerment induced by his fear of discontinuing the 
antidepressants, representing a damaging loss of self-efficacy (Bandura, 2006). He describes a 
state of self-alienation in which he disengages from his feelings, and develops a sense of 
irresponsibility and externality from himself, mirroring at the level of emotion and identity the 
dissociative embodiment noted in the previous theme: 
 
“I’ve come to a point where I’ve sort of stopped engaging with how I might feel and 
I’m just kind of now saying this pill will just kind of get me through the day and then I 
developed a fear whereby I would be like if I stop taking this pill I’m not going to, I’m 
going to be back where I was [um] which is quite a disempowering thing” (Tom) 
 
“it was a kind of psychological almost like a sort of dependency, like the only reason 
I’m feeling okay is because of this pill, it’s a kind of external xxx sort of feeling. [Um] 
and I felt that and I was actually kind of possibility quite negative because I wasn’t 
taking responsibility for my own health in a way” (Tom) 
 
Work by Williams (1984), and other researchers (Stevenson and Knudsen, 2008), suggests that 
recovery from illness involves processes of “narrative reconstruction” in which the course of 
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the illness is explained in such a way as to reaffirm the impression that life has a course and 
the self has a purpose. In this light, the conflicts expressed by our participants suggest that 
perceptions of antidepressant use can come to disrupt processes of narrative reconstruction 
by becoming associated with a sense of self-alienation and uncertainty about the real 





Participants were able to reflect on the ambivalent nature of their masculine roles and 
identities as both a positive and negative factor in their depression. George for example makes 
the observation that his duties as a husband and father provided a structure and purpose that 
gave him direction and pushed him to “keep going” during the hardest times, but also placed 
a burden of responsibility on him that foreshortened his recovery: 
 
“In a way sort of the, the weight of the responsibilities of being a husband and a 
father kind of helped because it meant that I had to keep going.  That there wasn’t 
an option.  [um] It would have been very easy to sort of sign off sick from work.  It 
would have been very easy to do that.  And certainly in my own case, that would 
have been the wrong thing to have done because then I would have lost the 




“…but if you could have taken away the responsibilities and the pressure, possibly 
even keeping the routine or substituting it with a different routine, then, yeah I think 
I would have got better a lot quicker” (George) 
 
Peter describes a similar nuance. He is proud of having had the “guts to carry on” and fight to 
provide a “normal life” for his family, but he is also aware that work and money pressures 
exacerbated his depression: 
 
“it was a fight to keep going and living with it and trying to live a normal life, you 
know, because I’ve done well because I’ve brought up a family and got a house and a 
car and I’ve worked all the way through which is unusual for a depressive really. So I 
feel I’ve been lucky and I’ve a lot of guts to carry on with it and I’ve always carried on 
as I say, I used to crawl, to make sure I had a shave and I’ve always tried to be alright 
with the kids and I‘ve forced myself to go to work as often as I could” (Peter) 
 
“I get promoted to be a planning manager [um] and that was a step too far because I 
was unhappy in that, I was getting more and more depressed again” […] “how money 
rules you” (Peter) 
 
Gibson et al. (2018) highlight the importance that men attribute to their role as the family 
breadwinner, whilst Emslie et al. (2006) note how these responsibilities may precipitate 
depression by creating stress. However, these studies do not identify the ways in which 
medication may come to play a role in this cycle by being seen as a way to allow men to cope 
with more stress, without changing underlying routines or stresses. George for example points 
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to how medication became a tool that allowed him to function, but didn’t address the root 
cause of his depression, thus making him a “functional zombie”: 
 
“it kind of worked in that it made me more functional.  I was a functional zombie.  I, I, 
I could function, I could work, I could read, I did have my motivations, my mental 
capacities back but I was still depressed.” (George) 
 
Peter reflects on how he had wanted to quit his job, but did not do so out of a sense of duty to 
his family, so he continued to take the medication, as a way to just “carry on”: 
 
“it was something I wanted to do but I didn’t feel like putting my wife and my family 
through difficulties to please myself” (Peter) 
 
“I just did things, I just went from day to day, take my pill, carry on” (Peter) 
 
Our analysis suggests that it is important to recognize how medication can come to be 
deployed simply to allow men to continue being “strong” and carry the heavy burden of 
responsibilities that may be a contributing factor to the causes of their depression in the first 
place. Gibson et al. (2018) report how men may use stoic language or masculinity affirming 
metaphors of combat in describing their “fight” against depression, yet our participants also 
pointed to important processes of “acceptance” and identity change as critical to their 




“Getting better is about thinking no that's wrong actually, and moving on, it's not 
about fighting” (Samuel) 
 
“I think I've kind of accepted that that it is something that's there now.” (Samuel) 
 
“you can fabricate the personality to try and fit into kind of social conventions and 
social rules and you can actually have a very poor sense of your own identity and 
that’s quite a painful process to actually think about and accept that [um] but I do 




The above analysis highlights how certain experiences of altered reality and embodiment - 
including sexual abnormality, disembodiment and dissociation, and loss of enjoyment and 
creative vitality - attributed as side effects of the medication by participants, can come to be 
experienced as disrupting identity-defining roles and activities. These included the men’s roles 
as intimate partners, but also more generally their ability to enjoy and create, perceived by 
some participants as part of what was hoped for in recovery. This concurs with much previous 
research on the importance of physical side-effects on user experience of antidepressants 
(Read et al., 2014; Cartwright et al., 2018), and on how this may become gendered in particular 
ways (Gibson et al., 2018). 
The above analysis also highlights the centrality of conflicts at psychological, symbolic 
and narrative levels as critical to users’ attempts to rebuild their sense of identity, agency and 
self-efficacy in the process of recovery. The men reported not only losing touch with their 
 
21 
bodies and sensuality, but also lost touch with the validity of their own introspections, and a 
sense of narrative coherency in which they could account for their behaviour and internal 
states. Recovery from illness involves processes of “narrative reconstruction” in which the 
course of the illness is explained in a life-affirming way (Williams, 1984), yet antidepressants 
can come to be associated with self-alienation and uncertainty about the real determinants of 
the life course, and the devaluing of one’s agency as a source of change. These difficulties are 
further intertwined with concerns about dependency on the medication, and fear of 
withdrawal. 
Our study also demonstrates how medical and psychotherapeutic practices and 
narratives can come in to conflict. As other studies have pointed out, availability of clear 
information about side effects and withdrawal, and the development of a good rapport 
between the prescribing doctor and patient, can facilitate the integration of the different 
models of intervention. This would allow medication users to validate insights in to the sources 
of their depression, and play a more agentic role in establishing their own therapeutic regimen 
(Garfield et al., 2003). Our study suggests that commitments at the heart of the male gender 
identity to do with independence and control may also need to be addressed if this integration 
is to occur successfully, concurring with findings from other studies (Emslie et al., 2006; 
Robertson et al., 2015), such that men can frame their medication use as an expression of 
control, instrumental change and responsibility. 
Finally, our study raises questions about using medication as a technology that allows 
men to “cope” with typically masculine roles and responsibilities that may in fact be one of the 
stresses contributing to their depression, in particular those of husband, father and “bread-
winner”, although these paradoxically also provide an important sense of structure and 
purpose. As Seidler et al (2018) recommend, services may benefit from acknowledging the 
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contributions of positive masculinities, supporting and promoting men’s diverse patterns of 
masculinity, whilst also creating safe spaces where men can challenge the more destructive 
patterns of masculinity. Indeed, it has been suggested that conflicts around different 
components of the male identity may be differentially related to depression. Conflicts around 
success and achievement seem to be key variables that determine vulnerability to depression, 
as opposed to issues of restricted emotionality, which may be more closely associated with 
attitudes to help-seeking (Good and Wood, 1995; Robertson et al., 2015). Medication use 
could be integrated with other forms of support that foster self-acceptance and the 
development of more healthy forms of masculinity and work-life balance, allowing men to 
restructure their lives to decrease stress whilst still maintaining purpose and responsibility.  
Health education and training oriented to methods for engaging men in treatment 
models could better equip clinicians with the knowledge and skills needed to support male 
clients (Seidler et al. 2018), without also becoming complicit in reinforcing dominant models 
of stoicism and emotional detachment where this is not expedient to recovery. Research 
exclusively and explicitly focusing on men is also essential in order to better understand the 
male depression phenotype and disentangle it from traditional biased views (Smith et al., 
2018). Addressing men’s complex lived experience of antidepressant use could help to make 
mental health services more accessible to this currently underrepresented population (Affleck 
et al., 2018; Seidler et al., 2018), and maximize the effectiveness of antidepressants as part of 
a wider set of practices aimed at alleviating depression and promoting agency. 
The analysis presented in this paper aims to generate further research on a topic that 
has critical ramifications for men’s mental health and effective clinical practice. Future 
research should aim to transcend the limitations faced in this study. Conducted without 
external funding, this study was limited to analyzing secondary data, with a small sample size. 
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The appropriate analytic method for such a small sample is open to question, and 
interpretative phenomenological analysis may have been more appropriate. However, 
thematic analysis as a method is open to the flexible application of theories along a range of 
epistemological positions (Braun and Clarke, 2006), and was a good fit with the critical realist 
orientation of the research questions, allowing the interpretation of both experiences and 
their context (Bonnington & Rose, 2014). 
The selection of transcripts to be analyzed was also non-randomized, picked 
deliberately from a small subsection of the HERG archive by the lead researcher to give a 
selection of attitudes towards antidepressant medication, and produce a range of ages. Only 
one participant was of a minority ethnic group, none were aged below 29, and none openly 
identified as bi- or homosexual on the healthtalk.org website. Given the small sample size, 
homogeneity may actually be advantageous (rather than having ‘token’ participants singularly 
representing different backgrounds), and more homogeneity in terms of age in our sample 
may have been preferable, given generational differences in masculinity. But future research 
with larger random samples should aim to engage a diverse range of participants. Moreover, 
whilst this paper benefitted from co-authorship and review, the main analysis was conducted 
primarily by the one lead researcher, who has his own reservations about the normalization of 
antidepressant use, and his own gendered identity. 
This paper has foregrounded some key themes and questions to be explored further. 
These include not only issues of altered embodiment and dissociation in medication use, but 
also the role of life-narratives and the construction of an agentic self in recovery, as well as the 
interaction between medication use and the ambivalent nature of masculinities that seem to 
both constrain but also empower men in their recovery. An open engagement with these 
difficulties and concerns around antidepressant use in men, set in the context of a validating 
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but also critical discussion on masculinity, may help to make psychopharmacological treatment 
for depression more effective and accessible for male populations, and better integrated with 
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